There is interest in using cannabidivarin for seizure disorder, nausea, long-term swelling (inflammation) in the digestive tract, and other conditions, but there is no good scientific evidence to support these uses.
How does it work ?
Uses & Effectiveness
Possibly Ineffective for
- Seizure disorder (epilepsy). Taking cannabidivarin for 2 weeks doesn't appear to reduce seizures in people with poorly controlled seizure disorder.
Insufficient Evidence for
- Nerve pain. Early research suggests that taking cannabidivarin for 4 weeks does not seem to reduce nerve pain in people with HIV.
- A rare, inherited disorder that causes obesity, short stature, and learning disability (Prader-Willi syndrome or PWS).
- A type of inflammatory bowel disease (ulcerative colitis).
- A type of inflammatory bowel disease (Crohn disease).
- Duchenne muscular dystrophy.
- Fragile X syndrome.
- Multiple sclerosis (MS).
- Rett syndrome.
- Other conditions.
Special Precautions and Warnings
We currently have no information for CANNABIDIVARIN (CBDV) Interactions.
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version. © Therapeutic Research Faculty 2018.